News

Widely-available Drug May Benefit Glioblastoma Treatment Based on data from NBTS’s Defeat GBM Research Collaborative and with support from the Sharpe family, Dr. Paul Mischel (Stanford University) and his laboratory team found that the antidepressant drug, fluoxetine (common brand name: Prozac), potently targets tumor metabolism and inhibits epidermal growth factor (EGFR) signaling, triggering the killing of glioblastoma (GBM) cells. Dr. Mischel’s […] December 17, 2021

Sights & Sounds: Glioblastoma Awareness Day (#GBMDay) 2020 Perhaps Dr. Ned Sharpless, Director of the National Cancer Institute, summed up Glioblastoma (GBM) Awareness Day 2020 best when he said during NBTS’s Defeating GBM: A Virtual Town Hall event, “Events like this are really important to re-energize the community so we can join together and make progress in a disease that where progress has been […] July 23, 2020

Glioblastoma Models Get Boost From Cutting-Edge Tech Laboratory models are the backbone of cancer research and the development of new medicines. Researchers use models to study the biology of tumors like glioblastoma (GBM), as well as for testing the potential safety and effectiveness of drugs in different tumor types.  While today’s models for glioblastoma research are the best tools scientists have to […] February 19, 2020

Defeat GBM Research Collaborative: Progress Report (2018-2019) Over the past five years, the Defeat GBM Research Collaborative has stood as a testament to the power of ideas, collaboration, and the philanthropic partnership between patient advocacy nonprofits like NBTS and a dedicated community of supporters.  When we launched Defeat GBM as our flagship research initiative in 2014, we sought to do something different. […] February 10, 2020

Mavericks & Lions Wanted: Remembering Senators John McCain & Ted Kennedy and America’s Stake in the Fight Against Glioblastoma What we can learn from Senators John McCain and Ted Kennedy on the shared anniversary of their respective passings, both from glioblastoma August 25, 2019